日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors

转移性非精原细胞瘤一线化疗后行腹膜后淋巴结清扫术的肿瘤学结果

Matulewicz, R S; Baky, F; Liso, N; Williams, B M; Porwal, S; Assel, M; Carver, B S; Bajorin, D F; Motzer, R J; Bosl, G J; McHugh, D J; Reuter, V E; Tickoo, S K; Al-Ahmadie, H; Vickers, A J; Funt, S A; Feldman, D R; Sheinfeld, J

Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274

辅助性纳武利尤单抗治疗高危肌层浸润性尿路上皮癌:CheckMate 274 研究显示其疗效进一步增强

Galsky, Matthew D; Witjes, Johannes Alfred; Gschwend, Jürgen E; Milowsky, Matthew I; Schenker, Michael; Valderrama, Begoña P; Tomita, Yoshihiko; Bamias, Aristotelis; Lebret, Thierry; Shariat, Shahrokh F; Park, Se Hoon; Agerbaek, Mads; Jha, Gautam; Stenner, Frank; Ye, Dingwei; Giudici, Fabio; Dutta, Santanu; Askelson, Margarita; Nasroulah, Federico; Zhang, Joshua; Brophy, Lynne; Bajorin, Dean F

Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma

在既往接受过恩福妥单抗治疗的转移性尿路上皮癌患者中,沙妥珠单抗戈维替康的真实世界临床疗效

Sternschuss, M; Toumbacaris, N; Das, J P; Powles, T; Kotecha, R R; Laccetti, A L; Xiao, H; Feld, E; McHugh, D J; Keegan, N M; Bajorin, D F; Funt, S A; Shah, N J; Iyer, G; Aggen, D H; Teo, M Y; Ostrovnaya, I; Rosenberg, J E

Circulating Tumor DNA and Response to Cisplatin-based Chemotherapy in Patients with Metastatic Urothelial Carcinoma Enrolled in CALGB 90601 (Alliance)

CALGB 90601(Alliance)研究中转移性尿路上皮癌患者的循环肿瘤DNA与顺铂化疗反应的关系

Guercio, Brendan J; Whiting, Karissa; Shah, Ronak H; Ballman, Karla V; Halabi, Susan; Regazzi, Ashley M; Milbank, Jennifer H; Bajorin, Dean F; Beltran, Himisha; Morris, Michael J; Solit, David B; Berger, Michael F; Iyer, Gopa; Seshan, Venkatraman; Rosenberg, Jonathan E

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

尿路上皮癌不同组织学亚型的临床结果、基因组异质性和治疗考量

Chu, Carissa E; Chen, Ziyu; Whiting, Karissa; Ostrovnaya, Irina; Lenis, Andrew T; Clinton, Timothy N; Rammal, Rayan; Ozcan, Gamze Gokturk; Akbulut, Dilara; Basar, Merve; Chen, Jie-Fu; Chen, Ying-Bei; Gopalan, Anuradha; Fine, Samson W; Tickoo, Satish K; Arcila, Maria; Brannon, A Rose; Berger, Michael F; Cha, Eugene K; Goh, Alvin C; Donahue, Timothy F; Bajorin, Dean F; Teo, Min Yuen; Rosenberg, Jonathan E; Iyer, Gopa; Pietzak, Eugene J; Bochner, Bernard H; Reuter, Victor E; Sarungbam, Judy; Solit, David B; Al-Ahmadie, Hikmat

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease

紫杉醇、异环磷酰胺和顺铂作为生殖细胞肿瘤初始挽救化疗方案:预后良好和预后不良疾病的长期随访和预后

Gleeson, Jack P; Knezevic, Andrea; Bromberg, Maria; Patil, Sujata; Sheinfeld, Joel; Carver, Brett S; Bains, Manjit; Jones, David R; Bajorin, Dean F; Bosl, George J; McHugh, Deaglan J; Funt, Samuel A; Motzer, Robert J; Feldman, Darren R

Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial

阿特珠单抗单药治疗转移性尿路上皮癌:II期IMvigor210试验的最终分析

Rosenberg, J E; Galsky, M D; Powles, T; Petrylak, D P; Bellmunt, J; Loriot, Y; Necchi, A; Hoffman-Censits, J; Perez-Gracia, J L; van der Heijden, M S; Dreicer, R; Durán, I; Castellano, D; Drakaki, A; Retz, M; Sridhar, S S; Grivas, P; Yu, E Y; O'Donnell, P H; Burris, H A; Mariathasan, S; Shi, Y; Goluboff, E; Bajorin, D

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer

化疗耐药性肌层浸润性膀胱癌的自然史和基因组图谱

Lenis, Andrew T; Whiting, Karissa; Ravichandran, Vignesh; Tallman, Jacob E; Alam, Syed M; Chu, Carissa E; Jesus Escano, Manual De; Bochner, Emily; Katims, Andrew; Reisz, Peter A; Truong, Hong; Clinton, Timothy N; Telis, Leon; Dason, Shawn; McPherson, Victor; Teo, Min Yuen; Funt, Samuel; Aggen, David; Goh, Alvin C; Donahue, Timothy F; Cha, Eugene K; Donat, S Machele; Herr, Harry W; Dalbagni, Guido; Schultz, Nikolaus; Berger, Michael F; Bajorin, Dean F; Rosenberg, Jonathan E; Bochner, Bernard H; Ostrovnaya, Irina; Al-Ahmadie, Hikmat; Solit, David B; Iyer, Gopa; Pietzak, Eugene J

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

NEUROD1、ASCL1 和 POU2F3 的差异表达定义了膀胱小细胞/神经内分泌癌的分子亚型及其预后意义

Akbulut, Dilara; Whiting, Karissa; Teo, Min-Yuen; Tallman, Jacob E; Ozcan, Gamze Gokturk; Basar, Merve; Jia, Liwei; Rammal, Rayan; Chen, Jie-Fu; Sarungbam, Judy; Chen, Ying-Bei; Gopalan, Anuradha; Fine, Samson W; Tickoo, Satish K; Mehra, Rohit; Baine, Marina; Bochner, Bernard H; Pietzak, Eugene J; Bajorin, Dean F; Rosenberg, Jonathan E; Iyer, Gopa; Solit, David B; Reuter, Victor E; Rekhtman, Natasha; Ostrovnaya, Irina; Al-Ahmadie, Hikmat

Changes in the Perioperative Management and Outcomes of Patients With Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy at Memorial Sloan Kettering Cancer Center: Over 20 Years of Experience

纪念斯隆-凯特琳癌症中心20余年经验:上尿路尿路上皮癌根治性肾输尿管切除术围手术期管理及预后的变化

Yip, Wesley; Assel, Melissa J; Wong, Nathan C; Tracey, Andrew T; Alvim, Ricardo G; Nogueira, Lucas; Almassi, Nima; Singla, Nirmish; Clinton, Timothy N; Sjoberg, Daniel D; Al-Ahmadie, Hikmat; Hakimi, A Ari; Pietzak, Eugene J; Cha, Eugene K; Donahue, Timothy F; Dalbagni, Guido; Bochner, Bernard H; Bajorin, Dean F; Coleman, Jonathan A